Crown Bioscience Inc

Crown Bioscience Inc. is a privately held company headquartered in San Diego, California. Employing 248 individuals, the company generates an annual revenue of $1 billion. As a global contract research organization (CRO), Crown Bioscience specializes in providing a comprehensive suite of discovery, preclinical, and translational research platforms to advance oncology and immuno-oncology therapies. Crown Bioscience is renowned for its high-quality preclinical models, encompassing in vivo, in vitro, and ex vivo platforms. These models enable the company to partner with clients and thoroughly evaluate the efficacy and pharmacological profiles of drug candidates before they enter clinical trials. Their unique offerings include tumor organoid services utilizing HUB technology and the world's largest commercially available patient-derived xenograft (PDX) collection. Beyond these core services, Crown Bioscience also provides high-content imaging and a 3D ex vivo patient tissue platform. These advanced technologies allow for a deeper understanding of complex disease mechanisms. Additionally, the company offers a range of biomarker analysis and applied genomics services designed to optimize therapeutic benefits for patients. For more information about Crown Bioscience and its services, please visit www.crownbio.com.